Similar articles

• Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratories.

  Nakhleh RE, Grimm EE, Idowu MO, Souers RJ, Fitzgibbons PL. Nakhleh RE, et al. Arch Pathol Lab Med. 2010 May;134(5):728-34. doi: 10.5858/134.5.728. Arch Pathol Lab Med. 2010. PMID: 20441503
• Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures.

  Dyhdalo KS, Fitzgibbons PL, Goldsmith JD, Souers RJ, Nakhleh RE. Dyhdalo KS, et al. Arch Pathol Lab Med. 2014 Jul;138(7):876-84. doi: 10.5858/arpa.2013-0731-CP. Arch Pathol Lab Med. 2014. PMID: 24978913
• The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer.

  Diaz LK, Gupta R, Kidwai N, Sneige N, Wiley EL. Diaz LK, et al. J Histochem Cytochem. 2004 Apr;52(4):501-7. doi: 10.1177/002215540405200408. J Histochem Cytochem. 2004. PMID: 15034001
• HER2 testing in the UK: further update to recommendations.

  Walker RA, Bartlett JM, Dowsett M, Ellis IO, Hanby AM, Jasani B, Miller K, Pinder SE. Walker RA, et al. J Clin Pathol. 2008 Jul;61(7):818-24. doi: 10.1136/jcp.2007.054866. Epub 2008 Apr 1. J Clin Pathol. 2008. PMID: 18381380 Review.
• Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines.

  Hicks DG, Tubbs RR. Hicks DG, et al. Hum Pathol. 2005 Mar;36(3):250-61. doi: 10.1016/j.humpath.2004.11.010. Hum Pathol. 2005. PMID: 15791569 Review.